Abstract:Background: High-throughput sequencing has rapidly become an essential part of precision cancer medicine. But validating results obtained from analyzing and interpreting genomic data remains a rate-limiting factor. The gold standard, of course, remains manual validation by expert panels, which is not without its weaknesses, namely high costs in both funding and time as well as the necessarily selective nature of manual validation. But it may be possible to develop more economical, complementary means of validation. In this study we employed four synthetic data sets (variants with known mutations spiked into specific genomic locations) of increasing complexity to assess the sensitivity, specificity, and balanced accuracy of five open-source variant callers: FreeBayes v1.0, VarDict v11.5.1, MuTect v1.1.7, MuTect2, and MuSE v1.0rc. FreeBayes, VarDict, and MuTect were run in bcbio-next gen, and the results were integrated into a single Ensemble call set. The known mutations provided a level of "ground truth" against which we evaluated variant-caller performance. We further facilitated the comparison and evaluation by segmenting the whole genome into 10,000,000 base-pair fragments which yielded 316 segments. Results: Differences among the numbers of true positives were small among the callers, but the numbers of false positives varied much more when the tools were used to analyze sets one through three. Both FreeBayes and VarDict produced strikingly more false positives than did the others, although VarDict, somewhat paradoxically also produced the highest number of true positives. The Ensemble approach yielded results characterized by higher specificity and balanced accuracy and fewer false positives than did any of the five tools used alone. Sensitivity and specificity, however, declined for all five callers as the complexity of the data sets increased, but we did not uncover anything more than limited, weak correlations between caller performance and certain DNA structural features: gene density and guanine-cytosine content. Altogether, MuTect2 performed the best among the callers tested, followed by MuSE and MuTect. Conclusions: Spiking data sets with specific mutations -single-nucleotide variations (SNVs), single-nucleotide polymorphisms (SNPs), or structural variations (SVs) in this study-at known locations in the genome provides an effective and economical way to compare data analyzed by variant callers with ground truth. The method constitutes a viable alternative to the prolonged, expensive, and noncomprehensive assessment by expert panels. It should be further developed and refined, as should other comparatively "lightweight" methods of assessing accuracy. Given that the scientific community has not yet established gold standards for validating NGS-related technologies such as variant callers, developing multiple alternative means for verifying variant-caller accuracy will eventually lead to the establishment of higher-quality standards than could be achieved by prematurely limiting the range of innovative methods explored by members of the community.

MVSC: a multi-variation simulator of cancer genome.

SVSR: A Program to Simulate Structural Variations and Generate Sequencing Reads for Multiple Platforms

Structural variation and fusion detection using targeted sequencing data from circulating cell free DNA

Pysim-sv: a Package for Simulating Structural Variation Data with GC-biases

Hidden Biases in Germline Structural Variant Detection.

CRSCNV: A Cross-Model-Based Statistical Approach to Detect Copy Number Variations in Sequence Data

Comprehensive and realistic simulation of tumour genomic sequencing data

Severus: accurate detection and characterization of somatic structural variation in tumor genomes using long reads

Comprehensive and deep evaluation of structural variation detection pipelines with third-generation sequencing data

ModVAR: A Multimodal Framework for Comprehensive Driver Variant Prediction in Cancer

Copy Number Analysis Of Whole-Genome Data Using Bic-Seq2 And Its Application To Detection Of Cancer Susceptibility Variants

Evaluation of somatic copy number variation detection by NGS technologies and bioinformatics tools on a hyper-diploid cancer genome

A benchmarking framework for the accurate and cost-effective detection of clinically-relevant structural variants for cancer target identification and diagnosis

Comparing the performance of selected variant callers using synthetic data and genome segmentation

SVision-pro: comparative sequence-to-image representation and instance segmentation for de novo and somatic structural variant discovery

Overview of structural variation calling: Simulation, identification, and visualization

Detection of copy number variation from next generation sequencing data with total variation penalized least square optimization

Long-range somatic structural variation calling from matched tumor-normal co-assembly graphs

Systematic assessment of structural variant annotation tools for genomic interpretation

Mapping Copy Number Variation by Population-Scale Genome Sequencing.

Multiplex generation and single cell analysis of structural variants in a mammalian genome